Quality of Life and Health Economic Measurements in Allergic Patients Treated With Immunotherapy

Aalborg University571 enrolled

Overview

Grass pollen and house dust mites (HDM) are the most common allergens causing allergic rhino-conjunctivitis (RC) and/or asthma (A). Subcutaneous allergen specific immunotherapy (SCIT) reduces symptoms and use of medication. The purpose of SABAL is to assess the effect of SCIT on disease severity classifications in terms of number of days affected- and sick days on patients with grass pollen and/or HDM induced disease. These outcome measures will be gathered in one single measure: Quality Adjusted Life Years (QALY)

Study Type

OBSERVATIONAL

Enrollment

571

Conditions

Hypersensitivity Asthma Rhino-Conjunctivitis Quality of Life Effects of Immunotherapy

Eligibility

Sex: ALLMin age: 16 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Adults (\> 16 years) and allergic to grass pollen and/or house dust mites. Exclusion Criteria: * Allergic patients who had been immunotherapy treated before.